IKZF1 and acute lymphoblastic leukemia: This study evaluated whether IKZF1 and/or BTG1 silencing could impact the cell viability and transcript levels of glucocorticoid-responsive genes compared to dexamethasone treatment using the B-ALL 207 cell line as the experimental model.